New treatment for psychological and autoimmune conditions
Part of Bones, joints & muscles, Brain & nervous system, Mental health clinical trials.
This early-phase trial tests a new approach for people with certain psychological conditions, autoimmune diseases, neuropathy, or chronic fatigue syndrome. It aims to see if this treatment can help with symptoms related to these health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of anxiety, bipolar disorder, ADHD, dementia, or another psychological condition, OR an autoimmune disease like fibromyalgia, lupus, or thyroid disease, OR neuropathy or chronic fatigue syndrome.
- You are able to swallow tablets.
- You are 18 years old or older.
- You are not taking any blood-thinning medications (like warfarin, apixaban, or rivaroxaban).
- You are not considered chronically ill with a long-term serious health condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests a non-invasive biofield patch to see if it can help with anxiety, sleep, and energy. If you have regular anxiety episodes and are not taking certain medications, you may be able to join.
This study tests whether combining medicine adjustments, lifestyle changes (like diet and exercise), and optional brain stimulation can help people with schizophrenia, bipolar disorder, or depression feel better and function more independently. It may include a weight-loss medication if you're overweight or obese.
This Phase 2 trial tests whether a “synbiotic” supplement (a mix of probiotics and prebiotics) can reduce symptoms of schizophrenia or schizoaffective disorder. It may help by targeting gut-related immune and inflammation pathways that could affect brain symptoms.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This trial tests a new medication added to your current treatment for chronic depression that hasn't gotten better with at least two antidepressants and 12 therapy sessions. It might help when standard treatments aren't enough.
Hear when a new Bipolar Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.